BRADLEY KEITH 4

What Happened

Bradley Keith, a director of Integra LifeSciences Holdings Corp (IART), received a grant of 17,700 restricted stock units (RSUs) on May 7, 2026. Each RSU represents a contingent right to one share of IART common stock. On May 9, 2026, 882 shares were disposed under code F to satisfy a tax liability at $13.92 per share, generating proceeds of $12,277; this disposition appears to be a withholding to cover taxes rather than an open-market sale.

Key Details

• Transactions:
  • 2026-05-07 — Award (code A): 17,700 RSUs granted (derivative; $0.00 purchase price).
  • 2026-05-09 — Payment of tax liability (code F): 882 shares withheld/disposed at $13.92 = $12,277.
• Vesting: RSUs vest in full on the one-year anniversary of the grant (May 7, 2027) (Footnote F2).
• Footnotes: F1 confirms the grant is RSUs under the company’s equity incentive plan; F2 states full vesting in one year.
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Filing: Form 4 filed May 11, 2026 (appears timely based on reported transaction dates).

Context

• RSUs are a form of equity compensation (derivative award) that convert to shares upon vesting; the 17,700 RSUs do not represent immediately tradable shares until vesting.
• The 882-share disposition (code F) is a routine tax withholding/payment related to the award and is not the same as an open-market sale; such withholdings are common when companies grant RSUs.
• The cash value of the withheld shares (~$12.3k) is modest relative to typical executive equity grants and does not, by itself, indicate a change in insider sentiment.